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Abstract
Invasion of the trophoblast into the maternal decidua is regulated by both the trophoectoderm and the endometrial
stroma, and entails the action of tissue remodeling enzymes. Trophoblast invasion requires the action of metalloproteinases
(MMPs) to degrade extracellular matrix (ECM) proteins and in turn, decidual cells express tissue inhibitors of MMPs (TIMPs).
The balance between these promoting and restraining factors is a key event for the successful outcome of pregnancy. Gene
expression is post-transcriptionally regulated by histone deacetylases (HDACs) that unpacks condensed chromatin
activating gene expression. In this study we analyze the effect of histone acetylation on the expression of tissue remodeling
enzymes and activity of human endometrial stromal cells (hESCs) related to trophoblast invasion control. Treatment of
hESCs with the HDAC inhibitor trichostatin A (TSA) increased the expression of TIMP-1 and TIMP-3 while decreased MMP-2,
MMP-9 and uPA and have an inhibitory effect on trophoblast invasion. Moreover, histone acetylation is detected at the
promoters of TIMP-1 and TIMP-3 genes in TSA-treated. In addition, in an in vitro decidualized hESCs model, the increase of
TIMP-1 and TIMP-3 expression is associated with histone acetylation at the promoters of these genes. Our results
demonstrate that histone acetylation disrupt the balance of ECM modulators provoking a restrain of trophoblast invasion.
These findings are important as an epigenetic mechanism that can be used to control trophoblast invasion.
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Introduction
Implantation of the human embryo in the maternal endome-
trium is a key step for the successful establishment of pregnancy
and requires dialogue between the competent embryo and the
receptive endometrium [1]. Stromal decidualization is a critical
process that allows correct trophoblast invasion and placenta
formation [2]. This process includes morphological and biochem-
ical changes of the fibroblast-like stromal cells by the action of
ovarian steroids 17b-estradiol (E2) and progesterone (P4). A
network of signalling molecules and transcription factors which
controls the decidualization process has been identified [3,4].
Invasion of the trophoblast into the maternal decidua is
regulated by both the trophoectoderm and the stroma, and
requires the action of tissue remodelling enzymes [5]. Metallo-
proteinases (MMPs) are a family of zinc-dependent enzymes that
play a key role in degrading components of the extracellular
matrix (ECM). These enzymes regulate multiple physiological
events such as cell differentiation, cell motility, inflammation and,
in disease, tumour progression [6]. One of the major constituents
of decidual ECM is collagen IV, which is a substrate of the 72-kDa
and 92-kDa type IV collagenases, MMP-2 and MMP-9,
respectively [7]. Both MMPs are expressed and secreted by the
human endometrium and there is evidence that their function is
required for the tissue remodelling process during implantation or
for menstruation to occur in the absence of pregnancy [8,9,10].
Trophoblast invasion, like tumour invasion, requires the active
secretion of these proteases, which are capable of digesting the
ECM of the endometrium [11]. In contrast, decidual stromal cells
activate the expression of the tissue inhibitors of MMPs (TIMPs)
and down-regulate the urokinase plasminogen activator (uPA) [9].
It has been proposed that TIMPs act to limit ECM degradation by
MMPs in the endometrium during decidualization, thus limiting
embryonic invasion. The balance between these promoting and
restraining factors is crucial for the successful outcome of
pregnancy [12,13]. Aberrant expression or distribution of ECM
components in the decidual stroma has been associated with
preeclampsia or restricted intrauterine growth [14,15], and an
abnormal balance between MMPs and TIMPs has been related to
tumour invasion and metastasis in various human cancers,
including endometrial cancers [16,17].
An increasing body of evidence indicates that changes in
chromatin structure by histone modification appear to play an
important role in the regulation of gene transcription. Histone
modifications are very dynamic and reversible during normal
development and their misregulation is associated with cancer
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30508[18]. Histone acetylation, one of the best characterized histone
modifications, unpacks condensed chromatin facilitating the access
of transcription factors to target gene promoters. Histone
deacetylases (HDACs), along with histone acetyl transferases
(HATs), regulate the acetylation of histones and HDAC inhibition
can induce gene expression.
During the menstrual cycle, class I HDAC have been shown to
be constitutively expressed while global acetylation increases in the
early proliferative and secretory phases [19,20]. Moreover, it has
been reported that endometrial stromal cells cultured in vitro with
E2 and P4 increase H3 and H4 acetylation [21]. TSA is a potent
and specific organic compound that selectively inhibits HDAC
families of enzymes and in human endometrial stromal cells, TSA
treatment increases the levels of acetylated H3 and H4 [21].
The aim of the present study was to analyze the effect of histone
deacetylase inhibition in human endometrial stromal cells (hESCs)
and its impact on trophoblast outgrowth and invasion. Our results
demonstrate a dysregulation of the TIMPs and MMPs balance
due to induction of histone acetylation at the TIMP-1 and TIMP-
3 gene promoters. A similar effect was identified during hESCs in
vitro decidualization through TIMP-1 and TIMP-3 expression
induction due to histone acetylation at the TIMP-1 and TIMP-3
gene promoters.
Material and Methods
Ethics statement
This study was approved by the Institutional Review Board and
Ethics Committee of Instituto Universitario-Instituto Valenciano
de Infertilidad (Universidad de Valencia, Spain) (0901-EN-023-
FD code), and informed written consent was obtained from each
patient prior to tissue collection.
Endometrial stromal and epithelial cell isolation, cell
culture and TSA treatment
Endometrial samples, acquired after obtaining written consent
from patients, were collected on the day of oocyte retrieval from
healthy ovum donors aged 19–35 years old (n=25). Biopsies were
subjected to mild collagenase digestion to isolate human
endometrial stromal cells (hESCs) and human endometrial
epithelial cells (hEECs), as previously described [22]. The purity
of the cultures was assessed by vimentin (hESCs+, hEECs2) and
E-cadherin staining (hESCs2, hEECs+). hESCs were cultured in
DMEM/F12 medium containing 10% charcoal stripped foetal
bovine serum (FBS) and 0.1% antibiotics. Isolated hEECs were
cultured in 75% DMEM and 25% MCDB-105 (Sigma, St. Luis,
MO.) containing antibiotics and supplemented with 10% FBS and
5 mg/ml insulin. JEG-3 is an immortalized cell line derived from
human placental choriocarcinoma obtained from the American
Type Culture Collection (ATCC) (HTB-36; Manassas, VA). JEG-
3 was cultured in EMEM (Gibco, Invitrogen) medium containing
10% FBS and gentamicin (50 mg/ml) and fungizone (0.25 mg/
ml).
Human foreskin fibroblast cell line (hFFCs) was obtained from
the ATCC (CRL-2429; Manassas, VA) and was cultured in
IMDM medium supplemented with 10% FBS and 1% antibiotics.
HDAC inhibition was carried out with Trichostatin A (TSA)
(Sigma) at two different concentrations: 0.1 mM and 1 mM. hESCs
were cultured for 48 h with the drug treatment or vehicle
(controls) before any analysis. Cell viability was determined by
Trypan blue exclusion.
Decidualization was induced by culturing confluent hESCs in
DMEM/F12 medium containing 2% FBS with 0.5 mM 8-Br-
cAMP and 1 mM medroxyprogesterone (MPA) (Sigma) for 5 days
as previously described [23]. The medium was removed every 3
days. The hESCs decidualization phenotype was confirmed by
prolactin secretion in conditioned media by Elisa (Abbott Axsym
System, Abbot Park, IL).
hESC were treated with either 1 mM TSA for 48 h or 0.5 mM
8-Br-cAMP and 1 mM MPA for 5 days. Then cells were washed
with PBS and fresh DMEM-F12 medium containing 2% FSB was
added. The conditioned media were collected after 24 h and were
subjected to Western blot analyses.
Wound healing and invasion assays
Motility of hESCs after treatment with TSA was assessed using
the wound-healing assay. Briefly, hESCs were grown to confluence
and treated with 0.1 mM and 1 mM TSA or vehicle. After 48 h,
each well was scratched with a sterile pipette tip, the medium was
removed, cells were washed with PBS and cultured in fresh
medium. The width of the denuded area was subsequently
measured at 0 h and 24 h. Wound closure was calculated as the
percentage of the closed area of the initial wound width.
Invasion assays of hESCs were conducted with the Collagen
Transwell Invasion kits (Chemicon Int. Billerica, MA). The
hESCs previously treated with TSA or vehicle for 48 h were
resuspended in DMEM/F12 containing 5% BSA and 2.5610
5
cells were plated into 8-mm-pore size transwell inserts while
DMEM/F12 medium supplemented with 10% FBS was plated
on the bottom as a chemoattractant. Cells were allowed to invade
for 48 h. Invasion was measured by OD using a standard
microplate reader.
The invasion assay of cytotrophoblastic cell line JEG-3 [24] was
measured using the collagen-invasion chamber (see Figure 1E).
hESCs were treated for 48 h with 0.1 mM and 1 mM of TSA or
vehicle, the medium was replaced, cells were washed with PBS and
fresh medium was added for 24 h to obtain the conditioned media.
In the upper chamber, 2.5610
5 JEG-3 cells were resuspended in
the 24 hour-hESC conditioned medium and plated into 8-mm-
pore size transwell inserts. JEG-3 cells were allowed to invade for
48 h and invasion was measured by OD using a standard
microplate reader.
Gelatin Zymography
Twenty-four-hour serum-free conditioned media were collected
after 48 h TSA-treated and control hESC and were mixed with a
non-reducing sample buffer. Seven mg of protein per well were
separated by 10% polyacrylamide gels containing 1 mg/ml
gelatine. After electrophoresis, MMPs were renatured by washing
the gel in 50 mM Tris-HCl, pH 8, containing 2.5% Triton X-100
for 1 h at room temperature. MMPs were then activated by
incubating the gel at 37uC overnight in 50 mM Tris-HCl, pH 8,
containing 5 mM CaCl2 as previously described [25]. The gel was
stained with 0.1% (w/v) Coomasie Brilliant blue R-250 and
destained in distilled water/glacial acetic acid/methanol (4.5:1:4.5)
(v/v). Band densitometries were analyzed using the Image J
software to measure peak areas (http://rsbweb.nih.gov/ij/links.
html).
Embryo Collection, Co-Culture and
Immunohistochemistry
Procedures performed on animals were approved by the
Institutional Review Board and Ethics Committee of Instituto
Universitario-Instituto Valenciano de Infertilidad (Universidad de
Valencia, Spain). B6CBF1 strain mice were superovulated and
mated with males of the same strain. Two-cell embryos were
recovered on 2 day postcoitum and cultured for another 2-day
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TM medium (Vitrolife). Hatched embryos were
added to the confluent monolayers of hESCs treated 48 h
previously with TSA or vehicle. Co-cultures were fixed in 4%
paraformaldehyde in PBS with 0.1% Triton and 0.1% sodium
deoxycholate for 25 minutes. Cells were then blocked with PBS
0.3% Triton, 0.03% sodium azide and 1% BSA for 30 minutes.
Cells were incubated with primary antibodies (vimentin and E-
cadherin) in the same blocking solution buffer overnight at 4uC,
followed by the appropriate secondary conjugated antibody
(Molecular probes) for 1 h at room temperature. Cells were
mounted in Vectashield mounting medium containing DAPI
(Vector Laboratories). Trophoblast invasion was analysed 48 h
after embryo co-culture by measuring the spreading of the embryo
in the hESCs by immunofluorescence using the vimentin (Sigma)
and E-cadherin (Abcam Cambridge, UK) antibodies. Trophoblast
spreading was quantified by measuring the wound area in the
stromal cells made by the invading embryo using the Image J
software. A total of 8 embryos were used for the experiment and
each experiment was done in hESCs isolated from three different
biopsies.
RT and quantitative real-time PCR analysis
Total RNA was extracted from cell cultures using TRIzol
reagent (Invitrogen) following the manufacturer’s protocol. Firstly,
1 mg was reverse-transcribed with the M-MLV RT system
(Promega) to generate cDNA for the quantitative and semi-
quantitative analyses. Quantitative real-time PCR was performed
in triplicate using LightCycler FastStart DNA Master SYBR green
I (Roche) in a LightCycler 480 (Roche). The mRNA level was
normalized to GAPDH as a house keeping gene. The primers
sequences used were: MMP-2, 59-CAAAAACAAGAAGACATA-
CATCTT-39and 59-GCTTCCAAACTTCACGCTC-39; MMP-
9, 59-TGGGGGGCAACTCGGC-39and 59-GGAATGATCTA-
AGCCCAG-39; TIMP-1, 59-CTG TTG TTG CTG TGG CTG
ATA-39 and 59-CCG TCC ACA AGC AAT GAG T-39; TIMP-3,
59-ATGGTGTAGACCAGCGTGC-39and 59-AGGACGCCTT-
CTGCAACTC-39; uPA, 59-CACGCAAGGGGAGATGAA-39
and 59-ACAGCATTTTGGTGGTGACTT-39; RECK, 59-CT-
CGGTTTGTTGCAGTTATGC-39and 59-AGAGGCGCAAT-
AATTTTCCACT-39; GAPDH, 59-GAAGGTGAAGGTCGGA-
GTC-39and 59-GAAGATGGTGATGGGATTTC-39.
Western Blots
Conditioned media (CM) was obtained as previously described.
The proteins from the CM were precipitated with acetone at
220uC for at least 3 h and were centrifuged at 6000 g. Pellets
were resuspended in lysis buffer (300 mM NaCl, 20 mM Tris,
10 mM EDTA, 2% (v/v) Triton X-100, pH=7.3) and supple-
mented with a protease inhibitor cocktail.
The proteins (40 mg/lane) from the CM were separated on
10% SDS-polyacrylamide gels, transferred to polyvinylidene
difluoride membranes (BIO-RAD) and blotted overnight at 4uC
with antibodies specific to human TIMP-1 and TIMP-3
(Abcam) at 1:250 and 1:1000 dilutions, respectively. After
washing three times, blots were incubated with diluted
horseradish peroxidase-conjugated second antibodies (Santa
Cruz Biotechnology, St. Cruz, CA) for 1 h at room tempera-
ture. Blots were then washed extensively and developed using
enhanced chemiluminescence. Ponceau membrane staining was
used for data normalization.
Chromatin Immunoprecipitation Assay (ChIP) and PCR
ChIP was undertaken following the instructions recommended
by the kit supplier (Millipore, Cat no. 17-295). Briefly, hESCs
were treated for 24 h with 1 mM TSA or with 0.5 mM 8-Br-cAMP
and 1 mM MPA, washed with PBS, fixed using 1% formaldehyde
and lysed. Then chromatin was sonicated to give chromatin
fragments of around 500 bp in length. Chromatin was then
immunoprecipitated using ChIP Grade antibodies against acety-
lated Histone H3 (Millipore, 06-599), acetylated Histone H4
(Millipore, 06-598) and a nonspecific IgG-control antibody.
Sodium butyrate was used to inhibit DNA de-acetylation
throughout the lysis and incubation steps. Subsequently, immu-
noprecipitated DNA was washed, eluted and then purified using
ethanol precipitation and a Qiaquick DNA Purification kit
(Qiagen, West Sussex, UK) prior to the Q-PCR analysis. Q-
PCR was undertaken using the SYBR Green QPCR mastermix
(Sigma, Paisley, UK) in a Roche LC480 LightCycler. These values
were compared to an input control sample which represents a 10%
fraction of the total chromatin used in each IP.
Primers were designed to amplify a region in the 59 regulatory
regions of TIMP-1 and TIMP-3 near the transcription start site,
and promoter regions and CpG islands were suggested whenever
possible using WebPromoterScan (http://wye.cit.nih.gov/molbio/
proscan/).
Primers: TIMP-1 59-TTTCCTCTCTGCCACCCCTCACC-
A-39 and 59-CCGCCTCAGCGGAGAGCTTAG-39; TIMP-3 59-
CGGCAATGACCCCTTGGCTCG-39 and 59-GGAGCGCT-
TACCGATGTCGGA-39.
A non antibody control immunoprecipitate was also included in
each ChIP experiment to detect any background, if present, as
detected by qPCR, and was subtracted from the values found for
each immunoprecipitate in that experiment.
Statistics
At least three different biopsies were used per experiment and
measurements were taken in triplicate. Data are presented as the
mean and the standard error mean (SEM), and the statistical
Figure 1. TSA reduces hESC motility and limits trophoblast outgrowth and invasion. A, Wound healing assay was performed in 48 hour-
treated hESCs at two different TSA concentrations (0.1 mM and 1 mM) or a vehicle (control). The % of migrating cells was calculated as the area
covered by cells and is represented as an average of three independent experiments. Statistical analysis ** p,0.01. B, Invasion assays of the TSA-
treated hESCs were conducted in collagen transwells. hESCs were allowed to invade for 48 h after being previously treated with a vehicle (control), or
with 0.1 mM and 1 mM TSA. The histograms show a percentage of invading cells, with the invasion of the control cells designated as 100%.
Representative bright field images of the cells invading the underside of the filter are shown below the histograms. Data represent the mean of three
independent experiments. Statistical analysis,* p,0.05 and ** p,0.01. C, TSA-treated hESCs limit mouse embryos invasion potential. hESCs and the
mouse embryo were marked by Vimentin (red) and E-Cadherin (green), respectively. Nuclei were marked by DAPI (blue). The invasion area was
identified by the absence of stromal cells (red) and outlined by a white line. Bar size is 50 mm. D,1mM TSA-treated hESCs significantly decreased the
area of embryo spreading. Data represent the mean areas of at least 8 embryos in three independent experiments. Statistical analysis, ** p,0.01. E,
Schematic representation of the collagen transwell invasion assay used to measure the effect of the TSA-treated hESCs conditioned medium on
human trophoblast cells. See Material and Methods for procedure description. F, Histograms show the percentage of the invading cells, with invasion
of the control cells designated as 100%. Representative bright field images are shown below the histograms. Representative bright field images of
the cells invading the underside of the filter are shown below the histograms. Data represent the mean of three independent experiments.
doi:10.1371/journal.pone.0030508.g001
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(* p,0.05 and ** p,0.001).
Results
TSA reduces hESC motility and limits trophoblast
outgrowth and invasion
The spreading and invasion of the embryonic trophoblast
require the motility of maternal hESCs [26,27,28]. To explore the
effect of HDCA inhibitor TSA on stromal cell motility, we used
two different concentrations of TSA (0.1 mM and 1 mM) which did
not significantly affect the viability of cells at 48 h post-treatment
in a cell survival assay (Figure S1A). TSA at the highest
concentration (1 mM) significantly reduced cell migration (from
32% in control to 8% in TSA-treated hESCs, 75% compared to
control) in the in vitro wound-healing assay, while the lowest
concentration (0.1 mM) did not affect it (Figure 1A).
The effect of TSA on the ability of hESCs to move through a
collagen barrier was examined by the collagen-invasion chamber
assay. The percentage of endometrial stromal cells invading the
collagen layer compared to the positive control significantly
reduced in a dose-dependent manner (Figure 1B). hESCs treated
with 0.1 mM and 1 mM TSA were respectively 38% and 57% less
motile through the collagen layer than control cells. These findings
suggest that TSA reduces the motility capacities of hESCs.
We also used a heterologous co-culture in vitro model to
investigate the outgrowth and invasion of mouse embryos in TSA-
treated hESCs. The blastocysts placed on a confluent monolayer
of hESCs attached to them 24,48 h later [29]. This in vitro model
has been successfully used to study the role of Rho GTPase RAC1
in the motility of hESCs and, hence, embryo invasion [27,28]. We
used hESCs pre-treated with TSA for 48 h before embryo co-
culture to avoid any possible side effects of TSA on the embryo.
Hatched blastocysts were added to confluent TSA pre-treated
stromal cells, and the co-culture was fixed 48 h later and stained
for E-cadherin and vimentin as markers for trophoblast and
stromal cells, respectively. The attached embryos in the control
hESCs exhibited extended trophoblast spreading, while tropho-
blast outgrowth in 1 mM TSA pre-treated cells reduced by 50% if
compared to control cells (Figure 1C and 1D).
The effect of TSA-treated stromal cell on human trophoblast
cell invasion was studied by the collagen-invasion chamber assay.
The invasive potential of the JEG-3 cell line cultured in
conditioned media from 48 hour-TSA-treated stromal cells (0.1
or 1 mM) was measured (Figure 1E, and Material and Methods).
Invasion of the JEG-3 cells was inhibited by 42% in response to
1 mM TSA-treated hESCs conditioned medium if compared to the
vehicle (Figure 1F). Our results suggest that histone deacetylation
inhibition in hESCs restrain trophoblast invasion and outgrowth.
TSA induced an alteration in the balance of TIMPs and
MMPs in hESCs
Inhibition of histone deacetylases with 1 mM TSA in hESCs
significantly increased the expression of TIMP-1 (13-fold), and of
TIMP-3 (2.1-fold) at the mRNA level, while it decreased the
MMP2 (214.7-fold) and MMP9 (22.5-fold) levels analyzed by
semi-quantitative and quantitative PCR (Figure 2A and 2C).
Moreover, the levels of urokinase plasminogen activator (uPA)
were significantly reduced (223.2-fold). This protease is respon-
sible for ECM remodelling during menses, and plays a role in
tumour invasion and metastasis [9,30]. In contrast, another MMP
regulator, the tumour suppressor RECK [31], did not alter at the
mRNA level in the TSA-treated cells if compared to controls. At
the protein level, TIMP-3 was up-regulated in 24-hour condi-
tioned media from hESCs previously treated for 48 h with 1 mM
TSA or vehicle (Figure 2B). In contrast, we did not observe
increased TIMP-1 protein levels in the same conditioned media,
although these cells showed an increase at the mRNA level of
TIMP-1 (Figure 2B). Altogether, these results indicate that TSA-
treated hESCs lower the expression of the ECM proteases
enzymes, while they promote the expression of protease inhibitors.
To determine whether this is a specific effect on hESC, we
studied the effect of this drug on human endometrial epithelial
cells (hEECs) and human foreskin fibroblast cells (hFFCs). A
quantitative PCR analysis demonstrated that hEECs treated with
1 mM TSA behave similarly to hESCs with reduced MMP-2
(24.6-fold), MMP-9 (22-fold, although not significant) and uPA
(223-fold) mRNA levels, while they display an up-regulation of
TIMP-1 (13-fold), TIMP-3 (3.9-fold) and RECK (8.7-fold)
expression (Figure 2D). Instead, hFFCs respond differently to the
Figure 2. TSA alters the expression of the ECM modulating enzymes. A, Semi-quantitative PCR of ECM modulators MMP-2, TIMP-1, TIMP-3,
uPA and RECK in 48 h 1 mM TSA hESCs. Note that MMP-9 is not shown because the low expression levels were barely detectable in agarose gel. B,
Extracellular TIMP-1 and TIMP-3 Western blot analyses of protein extracts of 24 hour-conditioned media from 48 hour-hESCs treated with 1 mM TSA.
Ponceau staining of membranes was used as a protein loading control. Only the 60 kDa band of the ponceau gel is shown. Representative image of
three different analyses is shown. C, D and E, Quantitative PCRs for the MMP-2, MMP-9, TIMP-1, TIMP-3, uPA and RECK expression levels in human
endometrial stromal cells (hESCs, B), endometrial epithelial cells (hEECs, C) and foreskin fibroblast cells (hFFCs, D). Data represent the mean of three
independent experiments. Statistical analysis,* p,0.05 and ** p,0.01.
doi:10.1371/journal.pone.0030508.g002
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(60-fold), TIMP-1 and TIMP-3 did not significantly change, while
uPA was up-regulated (3.3-fold) and RECK was down-regulated
(21.72-fold) (Figure 2E).
These results suggest that the TSA effect pattern at the MMPs
and TIMPs mRNAs level is specific to both stroma and epithelial
endometrial cells.
TSA modulates the active versus latent forms of MMP-2
and MMP-9 in hESCs
To elucidate the molecular differences underlying the TSA-
treated hESCs responsible for the limited invasion potential of
trophoblast cells, a gelatine zymographic analysis of the superna-
tant media from the TSA-treated stromal cells was performed to
assess the MMP-2 and MMP-9 protein levels and enzymatic
activities. Gelatin zymographs resolve gelatinases by their
molecular mass and permit a distinction to be made between
the latent (pro-MMPs) and active forms (act-MMPs) of MMPs. In
the control hESCs, we identified three clearly distinct bands of
gelatinase activity at 92 kDa (pro-MMP-9), 72 kDa (pro-MMP-2)
and 62 kDa (act-MMP-2), as previously described (Figure 3A). It is
noteworthy that the active form of MMP-9, was not observed. We
identified a decrease in not only the total amounts of MMP-2
(57%), in both the active and latent forms, but also in pro-MMP-9
(80%) in the hESCs treated with TSA if compared to controls
(Figure 3A–3C). The increased ratio between the latent and active
forms of MMP-2 (pro-MMP-2/active-MMP-2, 2.8 in controls, 4.8
in 0.1 mM TSA and 9.7 in 1 mM TSA) in the TSA-treated hESCs,
if compared to control cells, indicates that TSA reduces MMP-2
activity not only levels, probably due to an increase in one of its
inhibitors (TIMP-1 and/or TIMP-3, or others) (Figure 3D). Our
results highlight a role of histone acetylation in ECM remodelling,
that of modulating the balance between the active versus the latent
forms of MMPs.
TSA induces histone acetylation at the TIMP-1 and TIMP-
3 gene promoters
H3 and H4 histone acetylation at the TIMP-1 and TIMP-3
promoter regions was assessed by chromatin immunoprecipitation
(ChIP) with specific antibodies (Figure 4A and 4B). A 24-hour
treatment with 1 mM TSA in hESCs increased the amount of
immunoprecipitated TIMP-1 promoter associated with acetylated
H3 and H4 (3.0- and 3.5-fold, respectively) when compared to the
control vehicle-treated cells (Figure 4C). Similarly, immunopre-
Figure 3. Enzymatic activities of MMP2 and MMP-9 in TSA-treated hESCs. A, 24 hour-conditioned serum-free media collected from
48 hour–TSA-treated and control hESC were subjected to gelatin zymography to assess the activation state of MMPs. Three clearly distinct bands of
gelatinase activity were observed at 92 kDa (pro-MMP-9), 72 kDa (pro-MMP-2) and 62 kDa (act-MMP-2). It is noteworthy that the 86 kDa band, which
corresponds to the active form of MMP-9, was not observed. The image is representative of three independent experiments. B and C, Quantification
of the gelatin zymography results by densitometry of the MMP-2 bands shows a decrease in total MMP-2 and a decrease in the latent (pro-MMP-2)
and active forms (act-MMP-2) in TSA-hESCs treated cells. C, The latent form of MMP-9 (pro-MMP-9) also decreases in TSA-treated hESCs. D, The ratio
between the active and the latent forms of MMP-2 increases in TSA hESCs. Data represent the mean of three independent experiments. Statistical
analysis,* p,0.05 and ** p,0.01.
doi:10.1371/journal.pone.0030508.g003
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(3.2-fold), but not with H3 (Figure 4D). Chromatin binding
specificity was shown by control IgG’s inability to yield an
appropriate PCR product. These results demonstrate that histone
acetylation at the TIMP-1 and TIMP-3 promoters after TSA
treatment is associated with increased TIMP-1 and TIMP-3
mRNA expressions
Decidualization induced the TIMP-1 and TIMP-3
expressions and histone acetylation at the gene
promoter regions
The decidualization process has been associated with epigenetic
changes in vivo and in vitro; specifically H3 and H4 become
acetylated upon decidualization [20,21]. We postulated that
histone acetylation is involved in the extensive ECM remodelling
that stromal cells undergo during decidualization. In vitro
decidualized hESCs treated with cAMP+MPA for 5 days boosted
the levels of decidual marker protein prolactin (PRL) (Figure S1B),
increased the mRNA levels of TIMP-1 (4.5-fold) and TIMP-3
(32.7-fold), and lowered MMP-9 (216.6-fold), uPA (25.8-fold)
and RECK (21.78-fold) (Figure 5A). In contrast, MMP-2
remained unaltered. At the protein level, TIMP-1 and TIMP-3
were up-regulated in the 24 hour-conditioned media from hESCs
previously treated for 5 days with the decidual stimulus (Figure 5B).
It is reasonable to suspect that TIMP-1 and TIMP-3 induction by
the decidual stimulus could be mediated by histone acetylation.
ChIP assays in 24-hour cAMP+MPA-treated hESCs revealed an
increase not only in H4 acetylation (but not in H3) at the gene
promoter of TIMP-1, but also in H4 and H3 acetylation at the
TIMP-3 promoter (Figure 5C and 5D). Our results suggest that
histone acetylation could mediate the TIMP-1 and TIMP-3
expressions during in vitro decidualization.
Discussion
The formation of a functional placenta requires the extensive,
although well-controlled, invasion of trophoblast cells through
the stromal compartment [5]. Therefore, the mechanisms
controlling this process involve both the signals that promote
and limit trophoblast invasion. Trophoblast cells induce the
expression of MMPs and plasminogen activators which degrade
ECM components by promoting invasion, while decidual cells
modulate this potential through the activation of TIMPs
[32,33,34,35,36]. In addition, the motility potential of hESCs
at the implantation site facilitates trophoblast invasion by
anchoring the embryo onto the decidua, leading to placenta
formation and successful pregnancy [27,28]. All these processes
need to be precisely controlled at a molecular level to ensure
correct embryo invasion.
Treatment of mammalian cells with potent inhibitors of
HDACs, such as TSA, activates or inhibits the expression of
about 2% of cellular genes [37]. Our study shows that TSA-
treated hESCs inhibit the expression of ECM proteases (MMP-2,
MMP-9 and uPA) while activating their inhibitors (TIMP-1 and
TIMP-3). Gain of TIMP-1 and TIMP-3 transcription is associated
with increased histone acetylation at the promoter of these genes.
This gene expression profile is associated with reduced embryo
invasion in the TSA-treated hESCs. Moreover, the conditioned
media from the TSA-treated hESCs diminish trophoblast cells
ability to invade the ECM in a collagen barrier invasion assay,
suggesting that the extracellular molecules secreted from the
treated hESCs have an impact by regulating this process. The
reduced trophoblast invasion described herein is in accordance
with not only diminished MMPs levels and activity, but with
increased extracellular TIMP-3 in the TSA-treated stromal cells
(Figure 6).
Figure 4. TSA induces histone acetylation at the TIMP-1 and TIMP-3 gene promoters. A and B, Schematic representation of the TIMP-1
and TIMP-3 gene promoter regions, relative position of the primers used for the Chip experiment to the translational start (ATG). Note the CpG island
within the promoter element in the TIMP-3 gene. C and D, Chromatin immunoprecipitation experiments using antibodies against global H3 and H4
acetylation were carried out on the TIMP-1 (C) and TIMP-3 (D) genes in 24 hour-1 mM TSA-treated hESCs. Relative amounts of immunoprecipitated
TIMP-1 and TIMP-3 promoter sequences compared to input chromatin were determined by real-time PCR. Data represent the mean of three
independent experiments. Statistical analysis,* p,0.05 and ** p,0.01.
doi:10.1371/journal.pone.0030508.g004
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PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30508In a standarized in vitro decidualization model, endometrial
stromal cells also inhibit MMPs and produce TIMPs to antagonize
the proteolytic activity of trophoblast MMPs in order to limit
invasion (our results) [38]. Our experiments indicate that in vitro
decidualized hESCs increase the TIMP-1 and TIMP-3 expres-
sions, but decrease MMP-9 and uPA (Figure 6).
Overall, our results are in agreement with a study by Sakai et al,
2003 which proposed that histone acetylation is involved in
ovarian steroid-induced decidualization [21]. Mainly, they found
that not only did H3 and H4 acetylation increase in response to
ovarian steroid hormones, but also a synergistic effect of HDACi
TSA with E2 and P4 which enhanced the up-regulation of decidual
marker genes, such as PRL and IGFBP-1. We observed H3 and
H4 acetylation in the TSA-treated hESCs and in in vitro
decidualized hESCs at the gene promoters of TIMP-1 and
TIMP-3, suggesting that the post-translational modifications of
histone tails could facilitate the transcriptional activation of these
genes (Figure 6). Future experiments will be needed to confirm if
histone acetylation mediates TIMP-1 and TIMP-3 expression
during in vitro and in vivo decidualization.
We also tested the possibility of a synergistic enhancement of the
cAMP+MPA-induced expression of TIMPs by TSA. The 48-hour
cultures of hESCs with the decidual stimulus (cAMP+MPA) and
TSA did not enhance the expression of TIMP-1 or TIMP-3 if
compared to cAMP+MPA alone (Figure 5E). One possibility is
that the decidual stimulus directs histone acetylation at the
promoter regions of these genes, as observed in the ChIP
experiments, and that the addition of TSA no longer enhances
this effect. These results suggest a general mechanism for
endometrial decidualization where E2 and P4 increase the levels
Figure 5. In vitro decidualized hESCs ECM modulators expression and Chip experiments at the TIMP-1 and TIMP-3 gene promoters.
A, Quantitative PCRs for MMP-2, MMP-9, TIMP-1, TIMP-3, uPA and RECK expression levels in 5 day-cAMP+MPA-treated hESCs.. B, Extracellular TIMP-1
and TIMP-3 Western blot analyses of the protein extracts of 24 hour-conditioned media from hESCs treated with cAMP and MPA for 5 days. Ponceau
staining of the membranes was used as a protein loading control. Only the 60 kDa band of the ponceau gel is shown. Representative image of three
different analyses is shown. C and D, Chromatin immunoprecipitation experiments using antibodies against global H3 and H4 acetylation were
carried out on the TIMP-1 and TIMP-3 genes in 24 hour-cAMP+MPA-treated hESCs. Relative amounts of immunoprecipitated TIMP-1 and TIMP-3
promoter sequences compared to input chromatin were determined by real-time PCR. E, Quantitative PCR for the TIMP-1 and TIMP-3 expression
levels in 48 hour-cAMP+MPA, 1 mM TSA and cAMP+MPA+1 mM TSA-treated hESCs. Note that there is no significant difference between these two
conditions at the level of the TIMP-1 and TIMP-3 gene expressions. Data represent the mean of three independent experiments. Statistical analysis,
*p ,0.05, ** p,0.01, a p,0.05, b p.0.05.
doi:10.1371/journal.pone.0030508.g005
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e30508of cAMP, thus influencing gene transcription via chromatin
remodelling. Specifically, we indicate a link between ECM
remodelling changes and the motility potential of decidualized
stromal cells with the transcriptional control by the epigenetic
histone acetylation mark (Figure 6).
HDAC inhibitors are currently being developed as cancer
therapeutics, mainly because of their ability to inhibit cancer cell
growth in vitro and in vivo, to induce apoptosis, and to enhance cell
differentiation [39,40]. Nonetheless, other studies propose that
HDACi promotes cell invasion in some cancer cells, partly by the
activation of uPA [41]. These reports confirm the need to study
the effects of these drugs on each different cell type. Our results
provide additional information as to how TSA affects the pattern
of ECM remodelling enzymes in endometrial cells: TSA inhibits
MMPs (MMP-2 and MMP-9) and uPA, while activating TIMPs
(TIMP-1 and TIMP-3) in a similar manner in endometrial stromal
and epithelial cells; however, this pattern is not conserved in TSA-
treated foreskin fibroblast cells. In conclusion, our results highlight
the role of histone acetylation during embryo invasion control by
the stromal compartment of the endometrium and are important
to further understand human placentation.
Some HDAC inhibitors are being studied as potential
candidates for epigenetic therapies of malignant tumours
[39,42]. Therefore, the results we present herein provide
information for future epigenetic therapies that target histone
acetylation in reproductive diseases such as endometriosis,
endometrial cancer or preeclampsia where an inadequate balance
of MMPs and its inhibitors have been reported [14,43,44].
Supporting Information
Figure S1 Viability and PRL assays in TSA and
cAMP+MPA treated cells. A, TSA treatment at 0.1 and
1 mM does not affect the viability of hESCs. B, in vitro decidualized
hESCs for 5 days with cAMP+MPA boost the Prolactin (PRL)
levels in conditioned media. Data represent the mean of three
independent experiments. Statistical analysis,* p,0.05.
(TIF)
Acknowledgments
We thank Francisco Dominguez and Juan Manuel Moreno Moya for
comments on the manuscript.
Author Contributions
Conceived and designed the experiments: CE IH CS. Performed the
experiments: CE IH SA. Analyzed the data: CE IH SA CS. Contributed
reagents/materials/analysis tools: CE IH AQ SM SA AP CS. Wrote the
paper: CE CS.
References
1. Paria BC, Reese J, Das SK, Dey SK (2002) Deciphering the cross-talk of
implantation: advances and challenges. Science 296: 2185–2188.
2. Gellersen B, Brosens IA, Brosens JJ (2007) Decidualization of the human
endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod
Med 25: 445–453.
3. Popovici RM, Kao LC, Giudice LC (2000) Discovery of new inducible genes in
in vitro decidualized human endometrial stromal cells using microarray
technology. Endocrinology 141: 3510–3513.
4. Garrido-Gomez T, Dominguez F, Lopez JA, Camafeita E, Quinonero A, et al.
(2010) Modeling Human Endometrial Decidualization from the Interaction
between Proteome and Secretome. J Clin Endocrinol Metab.
5. van den Brule F, Berndt S, Simon N, Coulon C, Le Goarant J, et al. (2005)
Trophoblast invasion and placentation: molecular mechanisms and regulation.
Chem Immunol Allergy 88: 163–180.
6. Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the
regulation of tissue remodelling. Nat Rev Mol Cell Biol 8: 221–233.
7. Iwahashi M, Muragaki Y, Ooshima A, Yamoto M, Nakano R (1996) Alterations
in distribution and composition of the extracellular matrix during decidualiza-
tion of the human endometrium. J Reprod Fertil 108: 147–155.
8. Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cannon P, et al. (1994)
Patterns of matrix metalloproteinase expression in cycling endometrium imply
differential functions and regulation by steroid hormones. J Clin Invest 94:
946–953.
9. Schatz F, Krikun G, Runic R, Wang EY, Hausknecht V, et al. (1999)
Implications of decidualization-associated protease expression in implantation
and menstruation. Semin Reprod Endocrinol 17: 3–12.
10. Salamonsen LA, Nie G (2002) Proteases at the endometrial-trophoblast
interface: their role in implantation. Rev Endocr Metab Disord 3: 133–143.
Figure 6. Models of the TSA-treated hESC and decidual hESCs. A, In control endometrial stromal cells, trophoblast invasion is massive due to
low levels of TIMPs and high levels of MMPs and uPA proteases. B, TSA-treated hESCs inhibits HDAC and promotes histone acetylation at the
promoters of TIMP-1 and TIMP-3 by increasing the transcription of these genes. In contrast, the levels and activities of MMPs and uPA decrease. These
ECM modulators changes reduced the motility of hESCs and the invasion of trophoblast cells. C,I nin vitro decidualized hESCs, the intracellular cAMP
levels increase and promote histone acetylation at the TIMP-1 and TIMP-3 gene promoters. Moreover, the activity and level of MMPs and uPA
decreases and, together, precisely control the invasion of trophoblast cells.
doi:10.1371/journal.pone.0030508.g006
TSA Limits Embryo Invasion in hESCs
PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e3050811. Bischof P, Meisser A, Campana A (2001) Biochemistry and molecular biology of
trophoblast invasion. Ann N Y Acad Sci 943: 157–162.
12. Lala PK, Chakraborty C (2003) Factors regulating trophoblast migration and
invasiveness: possible derangements contributing to pre-eclampsia and fetal
injury. Placenta 24: 575–587.
13. Knofler M (2010) Critical growth factors and signalling pathways controlling
human trophoblast invasion. Int J Dev Biol 54: 269–280.
14. Cockle JV, Gopichandran N, Walker JJ, Levene MI, Orsi NM (2007) Matrix
metalloproteinases and their tissue inhibitors in preterm perinatal complications.
Reprod Sci 14: 629–645.
15. Lockwood CJ, Oner C, Uz YH, Kayisli UA, Huang SJ, et al. (2008) Matrix
metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9
induction by tumor necrosis factor alpha and interleukin 1 beta in human first
trimester decidual cells. Biol Reprod 78: 1064–1072.
16. Bourboulia D, Stetler-Stevenson WG (2010) Matrix metalloproteinases (MMPs)
and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative
regulators in tumor cell adhesion. Semin Cancer Biol 20: 161–168.
17. Graesslin O, Cortez A, Fauvet R, Lorenzato M, Birembaut P, et al. (2006)
Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2
expression in normal, hyperplastic and neoplastic endometrium: a clinical-
pathological correlation study. Ann Oncol 17: 637–645.
18. Rodriguez-Paredes M, Esteller M (2011) Cancer epigenetics reaches mainstream
oncology. Nat Med 17: 330–339.
19. Krusche CA, Vloet AJ, Classen-Linke I, von Rango U, Beier HM, et al. (2007)
Class I histone deacetylase expression in the human cyclic endometrium and
endometrial adenocarcinomas. Hum Reprod 22: 2956–2966.
20. Munro SK, Farquhar CM, Mitchell MD, Ponnampalam AP (2010) Epigenetic
regulation of endometrium during the menstrual cycle. Mol Hum Reprod 16:
297–310.
21. Sakai N, Maruyama T, Sakurai R, Masuda H, Yamamoto Y, et al. (2003)
Involvement of histone acetylation in ovarian steroid-induced decidualization of
human endometrial stromal cells. J Biol Chem 278: 16675–16682.
22. Simon C, Piquette GN, Frances A, el-Danasouri I, Irwin JC, et al. (1994) The
effect of interleukin-1 beta (IL-1 beta) on the regulation of IL-1 receptor type I
messenger ribonucleic acid and protein levels in cultured human endometrial
stromal and glandular cells. J Clin Endocrinol Metab 78: 675–682.
23. Tang B, Guller S, Gurpide E (1993) Cyclic adenosine 39,59-monophosphate
induces prolactin expression in stromal cells isolated from human proliferative
endometrium. Endocrinology 133: 2197–2203.
24. Hannan NJ, Paiva P, Dimitriadis E, Salamonsen LA (2010) Models for study of
human embryo implantation: choice of cell lines? Biol Reprod 82: 235–245.
25. Troeberg L, Nagase H (2004) Zymography of metalloproteinases. Curr Protoc
Protein Sci Chapter 21: Unit 21 15.
26. Gellersen B, Reimann K, Samalecos A, Aupers S, Bamberger AM (2010)
Invasiveness of human endometrial stromal cells is promoted by decidualization
and by trophoblast-derived signals. Hum Reprod 25: 862–873.
27. Grewal S, Carver J, Ridley AJ, Mardon HJ (2010) Human endometrial stromal
cell rho GTPases have opposing roles in regulating focal adhesion turnover and
embryo invasion in vitro. Biol Reprod 83: 75–82.
28. Grewal S, Carver JG, Ridley AJ, Mardon HJ (2008) Implantation of the human
embryo requires Rac1-dependent endometrial stromal cell migration. Proc Natl
Acad Sci U S A 105: 16189–16194.
29. Carver J, Martin K, Spyropoulou I, Barlow D, Sargent I, et al. (2003) An in-vitro
model for stromal invasion during implantation of the human blastocyst. Hum
Reprod 18: 283–290.
30. Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type
plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:
1–22.
31. Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M, et al. (1998)
Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by
the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci U S A 95:
13221–13226.
32. Strickland S, Richards WG (1992) Invasion of the trophoblasts. Cell 71:
355–357.
33. Shimonovitz S, Hurwitz A, Dushnik M, Anteby E, Geva-Eldar T, et al. (1994)
Developmental regulation of the expression of 72 and 92 kd type IV collagenases
in human trophoblasts: a possible mechanism for control of trophoblast invasion.
Am J Obstet Gynecol 171: 832–838.
34. Zhang J, Salamonsen LA (1997) Tissue inhibitor of metalloproteinases (TIMP)-
1, -2 and -3 in human endometrium during the menstrual cycle. Mol Hum
Reprod 3: 735–741.
35. Anacker J, Segerer SE, Hagemann C, Feix S, Kapp M, et al. (2011) Human
decidua and invasive trophoblasts are rich sources of nearly all human matrix
metalloproteinases. Mol Hum Reprod.
36. Librach CL, Feigenbaum SL, Bass KE, Cui TY, Verastas N, et al. (1994)
Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity
and invasion in vitro. J Biol Chem 269: 17125–17131.
37. Van Lint C, Emiliani S, Verdin E (1996) The expression of a small fraction of
cellular genes is changed in response to histone hyperacetylation. Gene Expr 5:
245–253.
38. Nuttall RK, Kennedy TG (1999) Gelatinases A and B and tissue inhibitors of
metalloproteinases 1, 2, and 3 during in vivo and in vitro decidualization of rat
endometrial stromal cells. Biol Reprod 60: 471–478.
39. Johnstone RW (2002) Histone-deacetylase inhibitors: novel drugs for the
treatment of cancer. Nat Rev Drug Discov 1: 287–299.
40. Uchida H, Maruyama T, Nagashima T, Asada H, Yoshimura Y (2005) Histone
deacetylase inhibitors induce differentiation of human endometrial adenocarci-
noma cells through up-regulation of glycodelin. Endocrinology 146: 5365–5373.
41. Pulukuri SM, Gorantla B, Rao JS (2007) Inhibition of histone deacetylase
activity promotes invasion of human cancer cells through activation of urokinase
plasminogen activator. J Biol Chem 282: 35594–35603.
42. Ganesan A, Nolan L, Crabb SJ, Packham G (2009) Epigenetic therapy: histone
acetylation, DNA methylation and anti-cancer drug discovery. Curr Cancer
Drug Targets 9: 963–981.
43. Osteen KG, Yeaman GR, Bruner-Tran KL (2003) Matrix metalloproteinases
and endometriosis. Semin Reprod Med 21: 155–164.
44. Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, et al. (2002) Presence
of active gelatinases in endometrial carcinoma and correlation of matrix
metalloproteinase expression with increasing tumor grade and invasion. Cancer
94: 1466–1475.
TSA Limits Embryo Invasion in hESCs
PLoS ONE | www.plosone.org 10 January 2012 | Volume 7 | Issue 1 | e30508